• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Infectious Disease

Pertussis found to persist in UK children despite preschool booster vaccine

byJordan AndersonandAndrew Bishara
June 29, 2014
in Infectious Disease, Pediatrics, Public Health
Reading Time: 3 mins read
Share on FacebookShare on Twitter

1. Roughly 1 in 5 UK children presenting with persistent cough were found to be infected with pertussis despite receiving the preschool booster vaccine.

2. Children who received the preschool booster vaccine 7 or more years prior to the study were four times more likely to have pertussis compared to children who had received the booster within 3 years of the study.

Evidence Rating Level: 2 (Good)

Study Rundown: This study investigates the prevalence and severity of pertussis (Whooping cough) in the adolescent population to inform policy decisions regarding the introduction of an adolescent pertussis booster. Looking at a population of n=279 from 2010 to 2012 in the UK, researchers identified laboratory confirmed pertussis in 56 study participants (20%, 95% CI: 16% to 25%) who presented to their local GP with persistent cough. Additionally, participants who received the preschool booster vaccine seven or more years prior to the study were over 4 times more likely to be diagnosed with pertussis compared to those who had received the preschool booster one to three years prior. These findings reveal that roughly one in five UK children and adolescents are infected with pertussis. Researchers argue that these findings support the decision to implement an adolescent pertussis booster to help curb rates of pertussis infection in adolescents and adults. This study is the largest of its kind, but it still enrolled less than 300 participants. Regardless, the findings are telling and the recommendations outlined in the article should be strongly considered by the UK Joint Committee on Vaccination and Immunisation.

Click to read the study in British Medical Journal

Relevant reading: Accelerating control of pertussis in England and Wales

RELATED REPORTS

The rotavirus vaccine (ROTASIIL) may reduce the incidence of hospitalization for rotavirus gastroenteritis in children

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

Melatonin use is associated with lower proportions of rapid eye movement sleep in children

In-Depth [study]: Over the last four years there has been a marked increase in the incidence of pertussis-related persistent cough presented in UK primary care offices. Although, the UK has very good population coverage for the primary pertussis vaccination (~90%) and good coverage for the preschool booster vaccination (80%) there remains a significant disease burden associated with pertussis. In the US and many other developed nations (not including the UK) there has been an adoption of an adolescent pertussis booster to help curb the spread of pertussis infection in adolescents and adults. In 2005 the US introduced the adolescent Tdap vaccination which provides tetanus, pertussis, and diphtheria immunizations to engage this specific issue.

This study was conducted in response to calls for research from the UK Joint Committee on Vaccination and Immunisation. In this study, researchers identified patients, ages 5-15, presenting in Thames Valley primary care offices with persistent cough lasting three weeks or longer. Upon presenting with cough, patients’ oral fluid was then tested to confirm pertussis infection serologically. A surprising finding from the study was that children who received the preschool booster vaccination 7 or more years prior to the beginning of the study were 4.23 times as likely (risk ratio 4.23, 95% CI: 1.84 to 9.70) to have laboratory confirmed pertussis, compared to those who had the booster within 1 to 3 years prior to the study. This finding reveals the potential for individuals to lose pertussis immunity over time, even after receiving the preschool booster.

More from this author: Medicaid beneficiaries among most frequent visitors to the emergency department; Emerging coronavirus found to spread in healthcare facilities; CT scans linked to cancer risk in children;Slowdown in healthcare costs linked to economic and clinical factors;

 Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT. 

Tags: boosterchildrencoughinfectedpediatricspertussisvaccine
Previous Post

Induction of labor more successful with standardization

Next Post

Sexting linked to sexual activity in middle school students

RelatedReports

Emergency

The rotavirus vaccine (ROTASIIL) may reduce the incidence of hospitalization for rotavirus gastroenteritis in children

September 21, 2026
Behavioral dysregulation in infancy predicts later child mental health
Cardiology

Higher maternal body mass index is associated with increased risk of cardiovascular disease in offspring

September 12, 2026
Parents with poor sleep quality report sleep problems in kids
Pediatrics

Melatonin use is associated with lower proportions of rapid eye movement sleep in children

August 14, 2026
Parents of children with autism report greater difficulty accessing health care
Chronic Disease

The association between parental and offspring body mass index may be due to genetic confounding

June 30, 2026
Next Post
Social media effective adjunct for contraception education

Sexting linked to sexual activity in middle school students

No obesity paradox found between BMI, stroke, and death

Virtual visits linked to decreased stress in hospitalized children

Lower vulvar cancer-related mortality in African Americans

AAP recommends STI screening for adolescents and young adults

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Gepotidacin (Blujepa) is safe and effective in women with uncomplicated urinary tract infections
  • Most routine blood tests do not require prolonged fasting
  • Pairing cardiac magnetic resonance with electrocardiograms (ECGs) improved artificial intelligence (AI) assessments of cardiovascular diseases
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.